Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
The current price of GBIO.BOATS is $5.39 USD — it has decreased by -0.19% in the past 24 hours. Watch Generation Bio stock price performance more closely on the chart.
What is Generation Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Generation Bio stocks are traded under the ticker GBIO.BOATS.
How many employees does Generation Bio have?▼
As of April 18, 2026, the company has 115 employees.
In which sector is Generation Bio located?▼
Generation Bio operates in the Health & Wellness sector.
When did Generation Bio complete a stock split?▼
Generation Bio has not had any recent stock splits.
Where is Generation Bio headquartered?▼
Generation Bio is headquartered in Cambridge, United States.